A new panel of federal immunization advisers, appointed by HHS Secretary Robert F. Kennedy Jr., showcases their extensive expertise in vaccines and science, sparking discussions on public health.
In a bold move, the Trump administration is sending out 100 cease-and-desist letters to drug companies, aiming to eliminate misleading ads. This crackdown includes increased transparency about drug risks and closing loopholes that conceal vital safety information.
Health Secretary Robert F. Kennedy Jr. claims Tylenol use during pregnancy may link to autism, sparking controversy and speculation. HHS and Kenvue push back against the claims, emphasizing the need for scientific evidence.
In a heated Senate hearing, Secretary Robert F. Kennedy Jr. faced tough questions about his COVID vaccine policies, raising eyebrows among Republican senators who support Trump's Operation Warp Speed. Kennedy's skepticism about vaccine efficacy and funding cuts sparked significant tension.
The Trump administration's upcoming report claims a link between acetaminophen use during pregnancy and autism, stirring controversy despite lacking scientific backing. Experts warn against oversimplifying autism's causes.
A revolt among over 1,000 federal health workers has erupted against Health Secretary Robert F. Kennedy Jr., demanding his resignation due to concerns over his leadership and public health safety.
Nine former CDC directors raise alarms over HHS Secretary Robert F. Kennedy Jr.'s recent actions, claiming they jeopardize public health and safety in America. They call for congressional oversight and express deep concern over the dismantling of critical health systems.
Former CDC immunizations chief Dr. Demetre Daskalakis resigns in protest, expressing grave concerns about the agency's direction and public health under new leadership.
Sen. Bernie Sanders demands the resignation of HHS Secretary Robert F. Kennedy Jr. following chaos at the CDC, criticizing his anti-vaccine stance and calling for accountability in public health leadership.
In a surprising turn of events, Jim O'Neill has been appointed as the interim director of the CDC following a high-profile dispute involving former director Susan Monarez. What does this mean for public health?
